Company Earnings Update 3 minutesRegister for Free AccessLoblaw (TSX: L) 2Q19 Results: Food Growth Softens Coresight Research July 25, 2019 Executive Summary In 2Q19, ended June 15, Loblaw reported a meaningful weakening of comparable sales growth in its food segment. Food retail comp growth of 0.6% compared to 2.0% in the prior quarter and was well below company-measured food-price inflation of 3.6%. Drug retail comp growth strengthened to 4.0% in 2Q19, from 2.2% in the prior quarter. Management maintained FY19 guidance for positive same-store sales and a stable gross margin in the retail segment. Please Login to read the full report. Not a member? Register for a free user account. This document was generated for Other research you may be interested in: M&A in US Food and Beverage CPG: Three Key Themes—Category Expansion, Brand Focus and Evolving Consumer NeedsAnalyst Corner—AgeTech: Revolutionizing Aging in the US with Madhav PitaliyaAnalyst Corner—High-Tech Healing: Four Ways AI Is Revamping Healthcare, with Madhav PitaliyaIntroducing “Fast Luxury” and Its Implications for the Retail Market
